USE OF [(ARYLOXY)(HETEROARYL)]METHYLPIPERIDINE DERIVATIVES IN MANUFACTURE OF MEDICAMENTS FOR TREATMENT OF DEPRESSION

摘要

The present invention discloses use of a compound represented by formula I, or pharmaceutically acceptable salts thereof in the manufacture of medicaments for the treatment of depression. Specifically it relates to the triple inhibition effect of compounds of formula I on the reuptake of 5-HT, NE and DA. Their antidepressive effects may have broader indications and smaller neurotoxic side effects than single target antidepressants (such as fluoxetine) and dual targets antidepressants (such as duloxetine) currently used in clinic.